Point72 Asset Management

Point72 Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Point72 Asset Management’s Portfolio RARX Stock Details RARX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$9.19M	Sell
2019 Q2	$17.6M	Buy
2019 Q1	$4.59M	Buy
2018 Q4	$1.08M	Sell
2018 Q3	$1.42M	Buy
2018 Q1	–	Sell
2017 Q4	$850K	Buy